Communiqués Edesa Biotech, Inc.

Actions

EDSA

CA27966L3065

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 13/07/2026			Varia. 5j.	Varia. 1 janv.
6,810 ^USD	-2,85%		-9,20%	+379,58%

05/06	Les points forts de la mi-séance : Lululemon chute après ses résultats du T1 ; les ingénieurs d'Amazon critiquent les dépenses en IA ; Hoffman quitte le conseil d'administration de Microsoft	MT
05/06	Edesa Biotech : le paridiprubart associé à une baisse de la mortalité chez les patients souffrant d'insuffisance rénale aiguë	MT

Communiqués

11/06	Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors	AQ
05/06	Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury	AQ
19/05	Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference	AQ
14/05	Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results	AQ
31/03	Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit	AQ
26/03	Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment	AQ
24/02	Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study	AQ
13/02	Edesa Biotech Reports Fiscal 1st Quarter 2026 Results	AQ
12/12	Edesa Biotech Reports Fiscal Year 2025 Results	AQ
31/10/25	Edesa Biotech Announces Upcoming Conference Schedule	AQ
28/10/25	Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study	AQ
08/08/25	Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results	AQ
14/05/25	Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results	AQ
28/04/25	Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference	AQ
04/04/25	Edesa Biotech Announces Chief Financial Officer Transition	AQ
14/02/25	Edesa Biotech Reports Fiscal 1st Quarter 2025 Results	AQ
13/02/25	Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules	AQ
13/12/24	Edesa Biotech : Annual Report for Fiscal Year Ending 09 30, 2024 (Form 10 K)	PU
13/12/24	Edesa Biotech : Reports Fiscal Year 2024 Results Form 8 K	PU
13/12/24	Edesa Biotech Reports Fiscal Year 2024 Results	AQ
31/10/24	Edesa Biotech : Founder Makes Strategic Investment in the Company Form 8 K	PU
31/10/24	Edesa Biotech’s Founder Makes Strategic Investment in the Company	AQ
21/10/24	Edesa Biotech Announces Upcoming Conference Schedule	AQ
12/08/24	Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results	AQ
12/04/24	Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference	AQ